The Trump administration on Friday scrapped a Biden administration proposal to have Medicare cover anti-obesity drugs, ...

The Centers for Medicare and Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

Kennedy Jr. has criticized the class of weight loss drugs known as GLP-1s, arguing the obesity problem can be solved by ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

Whether or not you choose to cover weight loss drugs, offering holistic support can make a meaningful difference in employee ...

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

Dr Harriet Treacy, co-founder of Beyondbmi, spoke with EVOKE to explain that obesity is a disease that requires medical treatment, whereas many people are simply availing of the drugs to lose a few ...

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...